Follow
Claudia Bruedigam
Title
Cited by
Cited by
Year
Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon-α in a murine model of polycythemia vera
A Mullally, C Bruedigam, L Poveromo, FH Heidel, A Purdon, T Vu, ...
Blood, The Journal of the American Society of Hematology 121 (18), 3692-3702, 2013
1762013
NK cells require IL-28R for optimal in vivo activity
F Souza-Fonseca-Guimaraes, A Young, D Mittal, L Martinet, C Bruedigam, ...
Proceedings of the National Academy of Sciences 112 (18), E2376-E2384, 2015
932015
Telomerase inhibition effectively targets mouse and human AML stem cells and delays relapse following chemotherapy
C Bruedigam, FO Bagger, FH Heidel, CP Kuhn, S Guignes, A Song, ...
Cell stem cell 15 (6), 775-790, 2014
892014
Intact TP-53 function is essential for sustaining durable responses to BH3-mimetic drugs in leukemias
R Thijssen, ST Diepstraten, D Moujalled, E Chew, C Flensburg, MX Shi, ...
Blood, The Journal of the American Society of Hematology 137 (20), 2721-2735, 2021
832021
Autophagy is required for stem cell mobilization by G-CSF
L Leveque-El Mouttie, T Vu, KE Lineburg, RD Kuns, FO Bagger, BE Teal, ...
Blood, The Journal of the American Society of Hematology 125 (19), 2933-2936, 2015
472015
Distinct effects of ruxolitinib and interferon-alpha on murine JAK2V617F myeloproliferative neoplasm hematopoietic stem cell populations
RJ Austin, J Straube, C Bruedigam, G Pali, S Jacquelin, T Vu, J Green, ...
Leukemia 34 (4), 1075-1089, 2020
402020
EphA2 is a therapy target in EphA2-positive leukemias but is not essential for normal hematopoiesis or leukemia
S Charmsaz, K Beckett, FM Smith, C Bruedigam, AS Moore, F Al-Ejeh, ...
PloS one 10 (6), e0130692, 2015
272015
Telomerase in hematologic malignancies
C Bruedigam, SW Lane
Current Opinion in Hematology 23 (4), 346-353, 2016
182016
Hematopoietic stem and progenitor cell-restricted Cdx2 expression induces transformation to myelodysplasia and acute leukemia
T Vu, J Straube, AH Porter, M Bywater, A Song, V Ling, L Cooper, G Pali, ...
Nature communications 11 (1), 3021, 2020
172020
Acute myeloid leukemia stem cell function is preserved in the absence of autophagy
AH Porter, L Leveque-El Mouttie, T Vu, C Bruedigam, J Sutton, ...
Haematologica 102 (9), e344, 2017
132017
Targeting cell cycle and apoptosis to overcome chemotherapy resistance in acute myeloid leukemia
VY Ling, J Straube, W Godfrey, R Haldar, Y Janardhanan, L Cooper, ...
Leukemia 37 (1), 143-153, 2023
122023
Epigenetic activation of plasmacytoid DCs drives IFNAR-dependent therapeutic differentiation of AML
JM Salmon, I Todorovski, KL Stanley, C Bruedigam, CJ Kearney, ...
Cancer Discovery 12 (6), 1560-1579, 2022
122022
Jak2V617F driven myeloproliferative neoplasm occurs independently of interleukin-3 receptor beta common signaling
T Vu, R Austin, CP Kuhn, C Bruedigam, A Song, S Guignes, S Jacquelin, ...
Haematologica 101 (3), e77, 2016
92016
Telomerase-targeted therapies in myeloid malignancies
JA Waksal, C Bruedigam, RS Komrokji, CHM Jamieson, JO Mascarenhas
Blood Advances 7 (16), 4302-4314, 2023
72023
The preclinical efficacy of a novel telomerase inhibitor, imetelstat, in AML-a randomized trial in patient-derived xenografts
C Bruedigam, B Wackrow, A Song, AH Porter, SCW Lee, AS Moore, ...
Blood 128 (22), 578, 2016
52016
Autophagy is required for long-term hematopoietic stem cell (HSC) function and G-CSF-induced HSC mobilization
L Leveque, T Vu, RD Kuns, BE Teal, M Lor, KE Lineburg, C Bruedigam, ...
Blood, The Journal of the American Society of Hematology 122 (21), 892-892, 2013
42013
Oncogenic drivers dictate immune control of acute myeloid leukemia
RJ Austin, J Straube, R Halder, Y Janardhanan, C Bruedigam, ...
Nature Communications 14 (1), 2155, 2023
32023
Imetelstat-Mediated Alterations in Fatty Acid Metabolism To Induce Ferroptosis As Therapeutic Strategy for Acute Myeloid Leukemia
C Bruedigam, AH Porter, A Song, G Vroeg in de Wei, T Stoll, J Straube, ...
Nature Cancer, 2023
32023
Inhibition of telomerase with imetelstat is detrimental to leukemia stem cells in acute myeloid leukemia (AML)
C Bruedigam, FO Bagger, FH Heidel, C Kuhn, S Guignes, A Song, ...
Blood 124 (21), 2322, 2014
32014
Imetelstat-Mediated Alterations in Lipid Metabolism to Induce Ferroptosis As Therapeutic Strategy for Acute Myeloid Leukemia
C Bruedigam, AH Porter, A Song, T Stoll, J Straube, LT Cooper, G Cheng, ...
Blood 140 (Supplement 1), 487-488, 2022
22022
The system can't perform the operation now. Try again later.
Articles 1–20